Clinical Pharmacology of Stable coronary disease Flashcards

1
Q

How does angina arise

A

mismatch between myocardial oxygen supply and myocardial demand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What increases myocardial demand

A

Heart rate
Preload
Afterload
Myocardial contractility – systolic function
Myocardial relaxation – diastolic function
Myocardial wall stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is angina treated

A
  1. Relieve symptoms
    * Reduce workload
    * Improve coronary blood flow
  2. Slow/halt the disease process
  3. Prevent myocardial infarction
  4. Prevent premature death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the different pharmacotherapy for angina

A

Rate limiting
Vasodilators
Sodium channel activators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the different rate limiting options

A

Beta-adrenoreceptor antagonist
Calcium channel blocker (L-type)
Ivabradine (f-channel)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the different vasodilator options

A

Nitrates – nitric oxide
Calcium channel blocker
Potassium channel activator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the sodium channel activator options

A

Ranolazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the disease modifying pharmacotherapies

A

Antiplatelets
Cholesterol lowering

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the different antiplatelet drugs

A

Aspirin
Clopidogrel
Ticagrelor
Prasugrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the different cholesterol lowering drugs

A

HMG-CoA reductase inhibitors
Fibrates
PCSK-9 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the mechanism of action of beta-adrenoreceptors antagonists

A

Reversible inhibitor of beta 1 and 2 receptors
Blocks sympathetic system
Selective vs Non-selective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the benefits of beta blockers

A

Heart rate – reduce myocardial workload
Contractility
Systolic wall tension – improve relaxation
Increases diastolic perfusion time
Reduces rate of ischaemic events and mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the side effects of beta blockers

A

Asthma
Peripheral vascular disease
Raynaud’s syndrome
Acute heart failure
Bradycardia or heart block
Fatigue
Impotence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the selective and non-selective beta blockers

A

Cardio selective:
* Bisoprolol
* Metoprolol – shorter acting
* Atenolol

Non-selective:
* Carvedilol
* Propranolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the mechanism of action of calcium channel blockers

A

Prevent calcium influx into myocytes and smooth muscle arteries/arterioles by blocking L-type Ca channel
Dihydropyridine mostly relax smooth muscle
Non-dihydropyridines mostly reduce heart rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the benefits of calcium channel blockers

A

Heart rate - Exclusively NDHP like Verapamil/Diltiazem
Reduce contractility (NDHP)
Reduce afterload (DHP)
Increases diastolic perfusion time (NDHP)

17
Q

What are the side effects of calcium channel blockers

A

Peripheral oedema (DHP)
Bradycardia/heart block (NDHP)
Hypotension (Both)
Reduced LV function
Headache
Flushing

18
Q

What are the side effects of calcium channel blockers

A

Peripheral oedema (DHP)
Bradycardia/heart block (NDHP)
Hypotension (Both)
Reduced LV function
Headache
Flushing

19
Q

What are the dihydropyridine and non-dihydropyridines

A

Dihydropyridine (DHP)
* Amlodipine
* Felodipine
* Nifedipine

Non-dihydropyridine (N-DHP)
* Verapamil
* Diltiazem

20
Q

What is the mechanism of action of nitrates

A

Nitric Oxide mediated smooth muscle relaxation
Non-selective
Long-acting preparations most effective
Sublingual has utility for acute attacks

21
Q

What are the benefits of nitrates

A

Reduce preload and afterload – Therefore myocardial workload
Improve coronary flow via vasodilation (Epicardial arteries and improve blood supply)
Doesn’t reduce mortality

22
Q

What are the side effects of nitrates

A

Severe aortic stenosis
Hypotension
Headache

23
Q

What is the mechanism of action of potassium channel activator

A

Activates ATP sensitive potassium channels
causing potassium influx

Resultant inhibition of Calcium influx:
1. Negative inotrope
2. Smooth muscle relaxation (coronary and peripheral)

24
Q

What are the side effects of potassium channel activators

A

Hypotension
GI ulceration

25
Q

What is the mechanism of action of ivabradine

A

Inhibits channels located in SA node
Only works when patient is in sinus rhythm

26
Q

What are the benefits of ivabradine

A

Heart rate – when in sinus rhythm
Reduces rates of infarction

27
Q

What are the side effects of ivabradine

A

Bradycardia
SA node disease

28
Q

What is the mechanism of action of ranolazine

A

Inhibits late sodium current in myocardial cells
Inhibits rapid phase of delayed potassium rectifier current, (Na+/K+ balance across membrane)
Reduces intracellular calcium
Metabolic action via alpha 1 and beta 1 mediation of fatty acid oxidation

29
Q

What are the benefits of ranolazine

A

Reduced O2 demand due to reduced wall stress (easier to perfuse microcirculation)
Beneficial antiarrhythmic effects via Na+/K+ channels (uncertain utility)

30
Q

What are the side effects of ranolazine

A

Avoid use with CYP enzyme inhibitors
Prolongs QTc

31
Q

What is the function of HMG-CoA reductase inhibitors

A

Reduces cholesterol production:
Atorvastatin
Simvastatin
Rosuvastatin

32
Q

How is cholesterol absorbtion reduced

A

Ezetimibe – inhibits cholesterol uptake in gut
Liver forced to increase uptake from blood stream therefore lowing LDL levels
Often used in conjunction with statin

33
Q

What are the benefits of lipid lowering therapy

A

Reduced rate of MI
Plaque stabilisation
Reduce LDL and increase HDL

34
Q

What are the LDL targets

A

Low risk – 3.0
Moderate risk – 2.5
High risk (recent MI) – 1.8